Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
FXFe327wz0bXyhrb